EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieBeobachtungsstudieOpen Access · CC BY 4.0

Early life vitamin D and neurocognitive abilities at age 6–8 years: a randomized clinical trial and observational analysis

Vilja Seppälä, Samuel Sandboge, Elisa Holmlund-Suila, Helena Hauta-Alus, Sakari Lintula, Eero Kajantie, Outi Mäkitie, Sture Andersson, Katri Räikkönen, Kati Heinonen

European Child & Adolescent Psychiatry · 2026-02 · 35 (2) · 587-597

DOI: 10.1007/s00787-025-02891-7 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift European Child & Adolescent Psychiatry, online erschienen am 10.10.2025. Verfasst von Vilja Seppälä und 9 weiteren Autor:innen. Beteiligte Einrichtung: Welfare Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland. vilja.seppala@tuni.fi. Hauptthemen laut MEDLINE: Vitamin D, Child Development, Executive Function, Cholecalciferol. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tampere University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitamin D is suggested to impact neurodevelopment, yet the current evidence is conflicting. We tested if vitamin D 3 supplementation during the first two years of life, maternal 25-hydroxy-vitamin D (25(OH)D) concentration during pregnancy, and child’s 25(OH)D concentrations at 12 and 24 months are associated with neurocognitive abilities in 6.6-8.9-year-old children. Participants were from a Finnish vitamin D double-blind randomized clinical trial and classified themselves white. Children received either vitamin D 3 400-IU ( n = 189) or 1200-IU ( n = 209) daily until 24 months of age. Serum 25(OH)D was analyzed from mothers at mean of 11.2 weeks of gestation, and from children at 12.0 and 23.9 months (25(OH)D, mean (SD) = 83.8 (21.7), 102.3 (30.1), 105.5 (28.6) nmol/L, respectively). Total Intelligence quotient (IQ) score was assessed with Wechsler Intelligence Scale for Children (WISC-IV) and executive functioning with A Developmental Neuropsychological Assessment (NEPSY-II) and parent-rated Behavior Rating Inventory of Executive Function (BRIEF) questionnaire. Neurocognitive abilities at age 6–8 years did not differ between the supplementation groups or according to 25(OH)D concentration at 12 or 24 months (total IQ: β = 1.14, 95% CI -1.69;3.97, p = 0.43, executive functioning, NEPSY-II: β =-0.07, 95% CI -0.14;0.28, p = 0.49, executive functioning, BRIEF: β =-0.42, 95% CI -5.13;4.28, p = 0.86). Maternal 25(OH)D was not associated with executive functioning. However, both lower and higher maternal 25(OH)D concentrations during pregnancy were associated with child’s lower total IQ scores (vertex at 76.6 nmol/L, quadratic estimate p < 0.001) supporting the hypothesis of the role of vitamin D during fetal development. The study is registered with ClinicalTrials.gov (NCT01723852, 2012-11-07 and NCT04302987, 2020-03-06).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DChild DevelopmentExecutive FunctionCholecalciferolCognitionIntelligenceHumansFemaleChildMaleDouble-Blind MethodPregnancyDietary SupplementsInfantFinlandNeuropsychological TestsVitaminsChild, Preschool

Stichwörter der Autor:innen

25(OH)DChildrenNeurocognitive abilitiesVitamin d

Substanzen

Vitamin D25-hydroxyvitamin DCholecalciferolVitamins

Autor:innen und Institutionen

  • Welfare Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland. vilja.seppala@tuni.fi.
  • Welfare Sciences, Faculty of Social Sciences, Tampere University, Tampere, Finland.
  • Population Health Unit, Finnish Institute for Health and Welfare, Helsinki and Oulu, Finland.
  • Pediatric Research Center, Children's Hospital, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Research Program for Clinical and Molecular Metabolism (CAMM), Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Clinical Medicine Research Unit, University of Oulu, Oulu, Finland.

Förderung

  • Tampere University

Zitieren

APA

Seppälä, V., Sandboge, S., Holmlund-Suila, E., Hauta-Alus, H., Lintula, S., Kajantie, E., Mäkitie, O., Andersson, S., Räikkönen, K., & Heinonen, K. (2026). Early life vitamin D and neurocognitive abilities at age 6–8 years: a randomized clinical trial and observational analysis. European Child & Adolescent Psychiatry, 35(2), 587-597. https://doi.org/10.1007/s00787-025-02891-7

Vancouver

Seppälä V, Sandboge S, Holmlund-Suila E, Hauta-Alus H, Lintula S, Kajantie E, et al. Early life vitamin D and neurocognitive abilities at age 6–8 years: a randomized clinical trial and observational analysis. European Child & Adolescent Psychiatry. 2026;35(2):587-597. doi:10.1007/s00787-025-02891-7

BibTeX
@article{Seppl2026,
  author = {Seppälä, Vilja and Sandboge, Samuel and Holmlund-Suila, Elisa and Hauta-Alus, Helena and Lintula, Sakari and Kajantie, Eero and Mäkitie, Outi and Andersson, Sture and Räikkönen, Katri and Heinonen, Kati},
  title = {Early life vitamin D and neurocognitive abilities at age 6–8 years: a randomized clinical trial and observational analysis},
  journal = {European Child & Adolescent Psychiatry},
  year = {2026},
  volume = {35},
  number = {2},
  pages = {587--597},
  doi = {10.1007/s00787-025-02891-7}
}
Kostenlos starten →